SAMHD1 specifically restricts retroviruses through its RNase activity

[1]  L. Lagae,et al.  Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 , 2015, American journal of medical genetics. Part A.

[2]  Yujun Shen,et al.  Inhibition of Hepatitis B virus replication by SAMHD1. , 2014, Biochemical and biophysical research communications.

[3]  Daehyun Baek,et al.  The ribonuclease activity of SAMHD1 is required for HIV-1 restriction , 2014, Nature Medicine.

[4]  A. Gronenborn,et al.  Mechanism of Allosteric Activation of SAMHD1 by dGTP , 2013, Nature Structural &Molecular Biology.

[5]  O. J. Semmes,et al.  Restriction of Virus Infection but Not Catalytic dNTPase Activity Is Regulated by Phosphorylation of SAMHD1 , 2013, Journal of Virology.

[6]  Baek Kim,et al.  Host Factor SAMHD1 Restricts DNA Viruses in Non-Dividing Myeloid Cells , 2013, PLoS pathogens.

[7]  M. Benkirane,et al.  Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.

[8]  Baek Kim,et al.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. , 2013, Cell host & microbe.

[9]  Baek Kim,et al.  Restriction of diverse retroviruses by SAMHD1 , 2013, Retrovirology.

[10]  A. Gronenborn,et al.  Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection , 2013, The Journal of Biological Chemistry.

[11]  Baek Kim,et al.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. , 2013, Virology.

[12]  P. Schwille,et al.  Single-stranded nucleic acids promote SAMHD1 complex formation , 2013, Journal of Molecular Medicine.

[13]  B. Nocek,et al.  Nuclease Activity of the Human SAMHD1 Protein Implicated in the Aicardi-Goutières Syndrome and HIV-1 Restriction* , 2013, The Journal of Biological Chemistry.

[14]  R. König,et al.  SAMHD1 restricts HIV-1 infection in resting CD4+ T cells , 2012, Nature Medicine.

[15]  Y. Crow,et al.  SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells , 2012, Retrovirology.

[16]  Baek Kim,et al.  The Vpx Lentiviral Accessory Protein Targets SAMHD1 for Degradation in the Nucleus , 2012, Journal of Virology.

[17]  G. Superti-Furga,et al.  SAMHD1 is a nucleic‐acid binding protein that is mislocalized due to aicardi–goutières syndrome‐associated mutations , 2012, Human mutation.

[18]  F. Diaz-Griffero,et al.  Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac , 2012, Retrovirology.

[19]  Michael Emerman,et al.  The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. , 2012, Cell host & microbe.

[20]  Baek Kim,et al.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.

[21]  R. König,et al.  SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection , 2011, PLoS pathogens.

[22]  Thomas Hollis,et al.  Aicardi-Goutières Syndrome Gene and HIV-1 Restriction Factor SAMHD1 Is a dGTP-regulated Deoxynucleotide Triphosphohydrolase*♦ , 2011, The Journal of Biological Chemistry.

[23]  Geoff Kelly,et al.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.

[24]  Li Wu,et al.  SAMHD1: a new insight into HIV-1 restriction in myeloid cells , 2011, Retrovirology.

[25]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[26]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[27]  Y. Crow,et al.  Cerebral vasculopathy is a common feature in Aicardi–Goutières syndrome associated with SAMHD1 mutations , 2011, Proceedings of the National Academy of Sciences.

[28]  D. Levy,et al.  A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells , 2010, Nature.

[29]  J. Lieberman,et al.  The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1 , 2010, Nature Immunology.

[30]  Y. Crow,et al.  Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. , 2009, Human molecular genetics.

[31]  Jonathan C. Fuller,et al.  Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.

[32]  R. Crouch,et al.  Ribonuclease H: the enzymes in eukaryotes , 2009, The FEBS journal.

[33]  B. Jia,et al.  The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies. , 2006, Virology.

[34]  J C Olsen,et al.  Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors , 2006, Gene Therapy.

[35]  J. Darlix,et al.  Transduction of Nondividing Human Macrophages with Gammaretrovirus-Derived Vectors , 2006, Journal of Virology.

[36]  J. Olsen,et al.  Restriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5α Proteins , 2005, Journal of Virology.

[37]  U. Chatterji,et al.  Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators , 2002, Journal of Virology.

[38]  K. Harrison‐Lavoie,et al.  Separation of copurifying GroEL from glutathione-S-transferase fusion proteins. , 2000, Protein expression and purification.

[39]  R. Montelaro,et al.  The S2 Gene of Equine Infectious Anemia Virus Is Dispensable for Viral Replication In Vitro , 1998, Journal of Virology.

[40]  S. Sarafianos,et al.  Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. , 1996, Biochemistry.

[41]  C. Beisel,et al.  Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein , 1993, Journal of virology.

[42]  V. Mizrahi,et al.  Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase. , 1990, Nucleic acids research.

[43]  J. Lieberman,et al.  The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1 , 2010 .